Back to results
US 7,129,377 B2Granted
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
AssigneeUniversity of Tennessee Research Foundation
InventorsDuane D. Miller, Leonid I. Kirkovsky, James T. Dalton, Arnab Mukherjee
Life of this patent
Estimating the term…
Abstract
The present invention relates to an androgen receptor alkylating compound, wherein the compound may include, inter alia, an active functional group, which permits the alkylation of the androgen receptor.
Claims2
A compound having the structure of the formula:
- where R1 and R3 are a hydrogen;
- R2 is a nitro;
- R4 is a hydrogen;
- R5 is a hydroxyl;
- R6 is an alkyl;
- A1 and A2 is the same or different, each is a direct link or an alkylene;
- X1 is an oxygen;
- and
- R7 is a phenyl substituted with an alkylamido group or a haloalkylamido group.
6 more elements
Dependencies are inferred from the claim text.